nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—CYP2D6—epilepsy syndrome	0.227	1	CbGaD
Labetalol—Lisdexamfetamine—Lacosamide—epilepsy syndrome	0.146	0.316	CrCrCtD
Labetalol—Indecainide—Oxcarbazepine—epilepsy syndrome	0.111	0.242	CrCrCtD
Labetalol—Salsalate—Carbamazepine—epilepsy syndrome	0.0715	0.155	CrCrCtD
Labetalol—Flurbiprofen—Diazepam—epilepsy syndrome	0.0668	0.145	CrCrCtD
Labetalol—Salsalate—Oxcarbazepine—epilepsy syndrome	0.0659	0.143	CrCrCtD
Labetalol—Mirabegron—SLCO1A2—epilepsy syndrome	0.000707	0.163	CrCbGaD
Labetalol—Ifenprodil—GRIN2B—epilepsy syndrome	0.000438	0.101	CrCbGaD
Labetalol—Mirabegron—BCHE—epilepsy syndrome	0.000317	0.0734	CrCbGaD
Labetalol—Tolterodine—CHRM3—epilepsy syndrome	0.000263	0.0607	CrCbGaD
Labetalol—Ketoprofen—SLCO1A2—epilepsy syndrome	0.000249	0.0576	CrCbGaD
Labetalol—Tolterodine—CHRM1—epilepsy syndrome	0.000245	0.0566	CrCbGaD
Labetalol—Tolterodine—CHRM2—epilepsy syndrome	0.0002	0.0462	CrCbGaD
Labetalol—Formoterol—CYP2C19—epilepsy syndrome	0.000188	0.0434	CrCbGaD
Labetalol—Arformoterol—CYP2C19—epilepsy syndrome	0.000188	0.0434	CrCbGaD
Labetalol—Mirabegron—CYP2D6—epilepsy syndrome	0.000174	0.0403	CrCbGaD
Labetalol—Arformoterol—CYP2D6—epilepsy syndrome	0.000139	0.0322	CrCbGaD
Labetalol—Formoterol—CYP2D6—epilepsy syndrome	0.000139	0.0322	CrCbGaD
Labetalol—Mirabegron—ALB—epilepsy syndrome	0.00013	0.0301	CrCbGaD
Labetalol—Mirabegron—ABCB1—epilepsy syndrome	0.000124	0.0287	CrCbGaD
Labetalol—Tolterodine—CYP2C19—epilepsy syndrome	0.000123	0.0285	CrCbGaD
Labetalol—Salsalate—PTGS2—epilepsy syndrome	0.000106	0.0244	CrCbGaD
Labetalol—Tolterodine—CYP2D6—epilepsy syndrome	9.15e-05	0.0211	CrCbGaD
Labetalol—Fenoprofen—PTGS2—epilepsy syndrome	8.74e-05	0.0202	CrCbGaD
Labetalol—Abdominal pain—Carbamazepine—epilepsy syndrome	7.98e-05	0.000354	CcSEcCtD
Labetalol—Body temperature increased—Carbamazepine—epilepsy syndrome	7.98e-05	0.000354	CcSEcCtD
Labetalol—Diarrhoea—Diazepam—epilepsy syndrome	7.98e-05	0.000354	CcSEcCtD
Labetalol—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	7.98e-05	0.000354	CcSEcCtD
Labetalol—Ill-defined disorder—Pregabalin—epilepsy syndrome	7.97e-05	0.000354	CcSEcCtD
Labetalol—Rash—Levetiracetam—epilepsy syndrome	7.94e-05	0.000353	CcSEcCtD
Labetalol—Dermatitis—Levetiracetam—epilepsy syndrome	7.93e-05	0.000352	CcSEcCtD
Labetalol—Asthenia—Zonisamide—epilepsy syndrome	7.92e-05	0.000352	CcSEcCtD
Labetalol—Mental disorder—Gabapentin—epilepsy syndrome	7.92e-05	0.000352	CcSEcCtD
Labetalol—Agranulocytosis—Topiramate—epilepsy syndrome	7.91e-05	0.000351	CcSEcCtD
Labetalol—Headache—Levetiracetam—epilepsy syndrome	7.89e-05	0.00035	CcSEcCtD
Labetalol—Erythema—Gabapentin—epilepsy syndrome	7.87e-05	0.00035	CcSEcCtD
Labetalol—Angioedema—Pregabalin—epilepsy syndrome	7.85e-05	0.000348	CcSEcCtD
Labetalol—Hypersensitivity—Clonazepam—epilepsy syndrome	7.84e-05	0.000348	CcSEcCtD
Labetalol—Dizziness—Vigabatrin—epilepsy syndrome	7.83e-05	0.000348	CcSEcCtD
Labetalol—Confusional state—Valproic Acid—epilepsy syndrome	7.82e-05	0.000347	CcSEcCtD
Labetalol—Pruritus—Zonisamide—epilepsy syndrome	7.81e-05	0.000347	CcSEcCtD
Labetalol—Hypersensitivity—Phenytoin—epilepsy syndrome	7.79e-05	0.000346	CcSEcCtD
Labetalol—Fenoprofen—ALB—epilepsy syndrome	7.78e-05	0.018	CrCbGaD
Labetalol—Propafenone—CYP2D6—epilepsy syndrome	7.78e-05	0.018	CrCbGaD
Labetalol—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.75e-05	0.000344	CcSEcCtD
Labetalol—Oedema—Valproic Acid—epilepsy syndrome	7.75e-05	0.000344	CcSEcCtD
Labetalol—Urticaria—Lamotrigine—epilepsy syndrome	7.75e-05	0.000344	CcSEcCtD
Labetalol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.75e-05	0.000344	CcSEcCtD
Labetalol—Bradycardia—Topiramate—epilepsy syndrome	7.75e-05	0.000344	CcSEcCtD
Labetalol—Malaise—Pregabalin—epilepsy syndrome	7.74e-05	0.000344	CcSEcCtD
Labetalol—Nausea—Propofol—epilepsy syndrome	7.74e-05	0.000344	CcSEcCtD
Labetalol—Vomiting—Fosphenytoin—epilepsy syndrome	7.72e-05	0.000343	CcSEcCtD
Labetalol—Diarrhoea—Felbamate—epilepsy syndrome	7.72e-05	0.000343	CcSEcCtD
Labetalol—Vertigo—Pregabalin—epilepsy syndrome	7.71e-05	0.000343	CcSEcCtD
Labetalol—Body temperature increased—Lamotrigine—epilepsy syndrome	7.71e-05	0.000342	CcSEcCtD
Labetalol—Abdominal pain—Lamotrigine—epilepsy syndrome	7.71e-05	0.000342	CcSEcCtD
Labetalol—Dizziness—Diazepam—epilepsy syndrome	7.71e-05	0.000342	CcSEcCtD
Labetalol—Syncope—Pregabalin—epilepsy syndrome	7.7e-05	0.000342	CcSEcCtD
Labetalol—Rash—Fosphenytoin—epilepsy syndrome	7.66e-05	0.00034	CcSEcCtD
Labetalol—Dermatitis—Fosphenytoin—epilepsy syndrome	7.65e-05	0.00034	CcSEcCtD
Labetalol—Asthenia—Clonazepam—epilepsy syndrome	7.64e-05	0.000339	CcSEcCtD
Labetalol—Headache—Fosphenytoin—epilepsy syndrome	7.61e-05	0.000338	CcSEcCtD
Labetalol—Hepatitis—Topiramate—epilepsy syndrome	7.61e-05	0.000338	CcSEcCtD
Labetalol—Palpitations—Pregabalin—epilepsy syndrome	7.59e-05	0.000337	CcSEcCtD
Labetalol—Asthenia—Phenytoin—epilepsy syndrome	7.59e-05	0.000337	CcSEcCtD
Labetalol—Nausea—Midazolam—epilepsy syndrome	7.57e-05	0.000336	CcSEcCtD
Labetalol—Hallucination—Topiramate—epilepsy syndrome	7.57e-05	0.000336	CcSEcCtD
Labetalol—Hypoaesthesia—Topiramate—epilepsy syndrome	7.57e-05	0.000336	CcSEcCtD
Labetalol—Muscle spasms—Gabapentin—epilepsy syndrome	7.57e-05	0.000336	CcSEcCtD
Labetalol—Diarrhoea—Zonisamide—epilepsy syndrome	7.56e-05	0.000336	CcSEcCtD
Labetalol—Loss of consciousness—Pregabalin—epilepsy syndrome	7.55e-05	0.000335	CcSEcCtD
Labetalol—Asthenia—Oxcarbazepine—epilepsy syndrome	7.55e-05	0.000335	CcSEcCtD
Labetalol—Pruritus—Clonazepam—epilepsy syndrome	7.53e-05	0.000334	CcSEcCtD
Labetalol—Vomiting—Vigabatrin—epilepsy syndrome	7.53e-05	0.000334	CcSEcCtD
Labetalol—Oedema peripheral—Topiramate—epilepsy syndrome	7.5e-05	0.000333	CcSEcCtD
Labetalol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.49e-05	0.000333	CcSEcCtD
Labetalol—Pruritus—Phenytoin—epilepsy syndrome	7.48e-05	0.000332	CcSEcCtD
Labetalol—Nausea—Levetiracetam—epilepsy syndrome	7.48e-05	0.000332	CcSEcCtD
Labetalol—Rash—Vigabatrin—epilepsy syndrome	7.47e-05	0.000332	CcSEcCtD
Labetalol—Dizziness—Felbamate—epilepsy syndrome	7.46e-05	0.000331	CcSEcCtD
Labetalol—Dermatitis—Vigabatrin—epilepsy syndrome	7.46e-05	0.000331	CcSEcCtD
Labetalol—Pruritus—Oxcarbazepine—epilepsy syndrome	7.44e-05	0.00033	CcSEcCtD
Labetalol—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.44e-05	0.00033	CcSEcCtD
Labetalol—Vision blurred—Gabapentin—epilepsy syndrome	7.42e-05	0.00033	CcSEcCtD
Labetalol—Headache—Vigabatrin—epilepsy syndrome	7.42e-05	0.000329	CcSEcCtD
Labetalol—Hypertension—Pregabalin—epilepsy syndrome	7.41e-05	0.000329	CcSEcCtD
Labetalol—Vomiting—Diazepam—epilepsy syndrome	7.41e-05	0.000329	CcSEcCtD
Labetalol—Tremor—Gabapentin—epilepsy syndrome	7.38e-05	0.000328	CcSEcCtD
Labetalol—Rash—Diazepam—epilepsy syndrome	7.35e-05	0.000326	CcSEcCtD
Labetalol—Dermatitis—Diazepam—epilepsy syndrome	7.34e-05	0.000326	CcSEcCtD
Labetalol—Visual impairment—Topiramate—epilepsy syndrome	7.33e-05	0.000326	CcSEcCtD
Labetalol—Ill-defined disorder—Gabapentin—epilepsy syndrome	7.31e-05	0.000324	CcSEcCtD
Labetalol—Dizziness—Zonisamide—epilepsy syndrome	7.3e-05	0.000324	CcSEcCtD
Labetalol—Headache—Diazepam—epilepsy syndrome	7.3e-05	0.000324	CcSEcCtD
Labetalol—Diarrhoea—Clonazepam—epilepsy syndrome	7.28e-05	0.000323	CcSEcCtD
Labetalol—Hypotension—Valproic Acid—epilepsy syndrome	7.24e-05	0.000322	CcSEcCtD
Labetalol—Asthenia—Carbamazepine—epilepsy syndrome	7.24e-05	0.000322	CcSEcCtD
Labetalol—Diarrhoea—Phenytoin—epilepsy syndrome	7.23e-05	0.000321	CcSEcCtD
Labetalol—Discomfort—Pregabalin—epilepsy syndrome	7.22e-05	0.000321	CcSEcCtD
Labetalol—Nausea—Fosphenytoin—epilepsy syndrome	7.22e-05	0.000321	CcSEcCtD
Labetalol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.2e-05	0.00032	CcSEcCtD
Labetalol—Angioedema—Gabapentin—epilepsy syndrome	7.19e-05	0.00032	CcSEcCtD
Labetalol—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.19e-05	0.000319	CcSEcCtD
Labetalol—Vomiting—Felbamate—epilepsy syndrome	7.17e-05	0.000319	CcSEcCtD
Labetalol—Pruritus—Carbamazepine—epilepsy syndrome	7.14e-05	0.000317	CcSEcCtD
Labetalol—Rash—Felbamate—epilepsy syndrome	7.11e-05	0.000316	CcSEcCtD
Labetalol—Dermatitis—Felbamate—epilepsy syndrome	7.11e-05	0.000316	CcSEcCtD
Labetalol—Malaise—Gabapentin—epilepsy syndrome	7.1e-05	0.000315	CcSEcCtD
Labetalol—Vertigo—Gabapentin—epilepsy syndrome	7.07e-05	0.000314	CcSEcCtD
Labetalol—Headache—Felbamate—epilepsy syndrome	7.07e-05	0.000314	CcSEcCtD
Labetalol—Confusional state—Pregabalin—epilepsy syndrome	7.07e-05	0.000314	CcSEcCtD
Labetalol—Flushing—Topiramate—epilepsy syndrome	7.06e-05	0.000314	CcSEcCtD
Labetalol—Syncope—Gabapentin—epilepsy syndrome	7.06e-05	0.000314	CcSEcCtD
Labetalol—Dizziness—Clonazepam—epilepsy syndrome	7.04e-05	0.000313	CcSEcCtD
Labetalol—Nausea—Vigabatrin—epilepsy syndrome	7.03e-05	0.000312	CcSEcCtD
Labetalol—Vomiting—Zonisamide—epilepsy syndrome	7.02e-05	0.000312	CcSEcCtD
Labetalol—Oedema—Pregabalin—epilepsy syndrome	7.01e-05	0.000311	CcSEcCtD
Labetalol—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.01e-05	0.000311	CcSEcCtD
Labetalol—Asthenia—Lamotrigine—epilepsy syndrome	7e-05	0.000311	CcSEcCtD
Labetalol—Dizziness—Phenytoin—epilepsy syndrome	6.99e-05	0.000311	CcSEcCtD
Labetalol—Rash—Zonisamide—epilepsy syndrome	6.96e-05	0.000309	CcSEcCtD
Labetalol—Paraesthesia—Valproic Acid—epilepsy syndrome	6.96e-05	0.000309	CcSEcCtD
Labetalol—Palpitations—Gabapentin—epilepsy syndrome	6.96e-05	0.000309	CcSEcCtD
Labetalol—Dermatitis—Zonisamide—epilepsy syndrome	6.96e-05	0.000309	CcSEcCtD
Labetalol—Dizziness—Oxcarbazepine—epilepsy syndrome	6.96e-05	0.000309	CcSEcCtD
Labetalol—Nausea—Diazepam—epilepsy syndrome	6.92e-05	0.000308	CcSEcCtD
Labetalol—Loss of consciousness—Gabapentin—epilepsy syndrome	6.92e-05	0.000307	CcSEcCtD
Labetalol—Headache—Zonisamide—epilepsy syndrome	6.92e-05	0.000307	CcSEcCtD
Labetalol—Dyspnoea—Valproic Acid—epilepsy syndrome	6.91e-05	0.000307	CcSEcCtD
Labetalol—Diarrhoea—Carbamazepine—epilepsy syndrome	6.91e-05	0.000307	CcSEcCtD
Labetalol—Pruritus—Lamotrigine—epilepsy syndrome	6.9e-05	0.000307	CcSEcCtD
Labetalol—Shock—Pregabalin—epilepsy syndrome	6.89e-05	0.000306	CcSEcCtD
Labetalol—Somnolence—Valproic Acid—epilepsy syndrome	6.89e-05	0.000306	CcSEcCtD
Labetalol—Dyspepsia—Valproic Acid—epilepsy syndrome	6.82e-05	0.000303	CcSEcCtD
Labetalol—Hypertension—Gabapentin—epilepsy syndrome	6.8e-05	0.000302	CcSEcCtD
Labetalol—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.77e-05	0.000301	CcSEcCtD
Labetalol—Vomiting—Clonazepam—epilepsy syndrome	6.77e-05	0.000301	CcSEcCtD
Labetalol—Alopecia—Topiramate—epilepsy syndrome	6.72e-05	0.000299	CcSEcCtD
Labetalol—Vomiting—Phenytoin—epilepsy syndrome	6.72e-05	0.000299	CcSEcCtD
Labetalol—Rash—Clonazepam—epilepsy syndrome	6.71e-05	0.000298	CcSEcCtD
Labetalol—Dermatitis—Clonazepam—epilepsy syndrome	6.71e-05	0.000298	CcSEcCtD
Labetalol—Nausea—Felbamate—epilepsy syndrome	6.7e-05	0.000298	CcSEcCtD
Labetalol—Vomiting—Oxcarbazepine—epilepsy syndrome	6.69e-05	0.000297	CcSEcCtD
Labetalol—Fatigue—Valproic Acid—epilepsy syndrome	6.68e-05	0.000297	CcSEcCtD
Labetalol—Dizziness—Carbamazepine—epilepsy syndrome	6.67e-05	0.000296	CcSEcCtD
Labetalol—Diarrhoea—Lamotrigine—epilepsy syndrome	6.67e-05	0.000296	CcSEcCtD
Labetalol—Headache—Clonazepam—epilepsy syndrome	6.67e-05	0.000296	CcSEcCtD
Labetalol—Rash—Phenytoin—epilepsy syndrome	6.67e-05	0.000296	CcSEcCtD
Labetalol—Mental disorder—Topiramate—epilepsy syndrome	6.67e-05	0.000296	CcSEcCtD
Labetalol—Dermatitis—Phenytoin—epilepsy syndrome	6.66e-05	0.000296	CcSEcCtD
Labetalol—Rash—Oxcarbazepine—epilepsy syndrome	6.63e-05	0.000295	CcSEcCtD
Labetalol—Pain—Valproic Acid—epilepsy syndrome	6.63e-05	0.000294	CcSEcCtD
Labetalol—Constipation—Valproic Acid—epilepsy syndrome	6.63e-05	0.000294	CcSEcCtD
Labetalol—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.63e-05	0.000294	CcSEcCtD
Labetalol—Headache—Phenytoin—epilepsy syndrome	6.62e-05	0.000294	CcSEcCtD
Labetalol—Erythema—Topiramate—epilepsy syndrome	6.62e-05	0.000294	CcSEcCtD
Labetalol—Discomfort—Gabapentin—epilepsy syndrome	6.62e-05	0.000294	CcSEcCtD
Labetalol—Headache—Oxcarbazepine—epilepsy syndrome	6.59e-05	0.000293	CcSEcCtD
Labetalol—Nausea—Zonisamide—epilepsy syndrome	6.56e-05	0.000291	CcSEcCtD
Labetalol—Hypotension—Pregabalin—epilepsy syndrome	6.55e-05	0.000291	CcSEcCtD
Labetalol—Confusional state—Gabapentin—epilepsy syndrome	6.48e-05	0.000288	CcSEcCtD
Labetalol—Dizziness—Lamotrigine—epilepsy syndrome	6.45e-05	0.000286	CcSEcCtD
Labetalol—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.43e-05	0.000285	CcSEcCtD
Labetalol—Oedema—Gabapentin—epilepsy syndrome	6.43e-05	0.000285	CcSEcCtD
Labetalol—Vomiting—Carbamazepine—epilepsy syndrome	6.42e-05	0.000285	CcSEcCtD
Labetalol—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.39e-05	0.000284	CcSEcCtD
Labetalol—Muscle spasms—Topiramate—epilepsy syndrome	6.37e-05	0.000283	CcSEcCtD
Labetalol—Rash—Carbamazepine—epilepsy syndrome	6.36e-05	0.000283	CcSEcCtD
Labetalol—Dermatitis—Carbamazepine—epilepsy syndrome	6.36e-05	0.000282	CcSEcCtD
Labetalol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.34e-05	0.000282	CcSEcCtD
Labetalol—Nausea—Clonazepam—epilepsy syndrome	6.32e-05	0.000281	CcSEcCtD
Labetalol—Headache—Carbamazepine—epilepsy syndrome	6.32e-05	0.000281	CcSEcCtD
Labetalol—Shock—Gabapentin—epilepsy syndrome	6.32e-05	0.000281	CcSEcCtD
Labetalol—Paraesthesia—Pregabalin—epilepsy syndrome	6.29e-05	0.000279	CcSEcCtD
Labetalol—Nausea—Phenytoin—epilepsy syndrome	6.28e-05	0.000279	CcSEcCtD
Labetalol—Dyspnoea—Pregabalin—epilepsy syndrome	6.25e-05	0.000277	CcSEcCtD
Labetalol—Nausea—Oxcarbazepine—epilepsy syndrome	6.25e-05	0.000277	CcSEcCtD
Labetalol—Vision blurred—Topiramate—epilepsy syndrome	6.24e-05	0.000277	CcSEcCtD
Labetalol—Somnolence—Pregabalin—epilepsy syndrome	6.23e-05	0.000277	CcSEcCtD
Labetalol—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.21e-05	0.000276	CcSEcCtD
Labetalol—Tremor—Topiramate—epilepsy syndrome	6.21e-05	0.000276	CcSEcCtD
Labetalol—Vomiting—Lamotrigine—epilepsy syndrome	6.2e-05	0.000275	CcSEcCtD
Labetalol—Urticaria—Valproic Acid—epilepsy syndrome	6.16e-05	0.000273	CcSEcCtD
Labetalol—Rash—Lamotrigine—epilepsy syndrome	6.15e-05	0.000273	CcSEcCtD
Labetalol—Ill-defined disorder—Topiramate—epilepsy syndrome	6.15e-05	0.000273	CcSEcCtD
Labetalol—Dermatitis—Lamotrigine—epilepsy syndrome	6.14e-05	0.000273	CcSEcCtD
Labetalol—Abdominal pain—Valproic Acid—epilepsy syndrome	6.13e-05	0.000272	CcSEcCtD
Labetalol—Body temperature increased—Valproic Acid—epilepsy syndrome	6.13e-05	0.000272	CcSEcCtD
Labetalol—Headache—Lamotrigine—epilepsy syndrome	6.11e-05	0.000271	CcSEcCtD
Labetalol—Fatigue—Pregabalin—epilepsy syndrome	6.04e-05	0.000268	CcSEcCtD
Labetalol—Hypotension—Gabapentin—epilepsy syndrome	6e-05	0.000267	CcSEcCtD
Labetalol—Nausea—Carbamazepine—epilepsy syndrome	6e-05	0.000266	CcSEcCtD
Labetalol—Constipation—Pregabalin—epilepsy syndrome	5.99e-05	0.000266	CcSEcCtD
Labetalol—Pain—Pregabalin—epilepsy syndrome	5.99e-05	0.000266	CcSEcCtD
Labetalol—Malaise—Topiramate—epilepsy syndrome	5.97e-05	0.000265	CcSEcCtD
Labetalol—Vertigo—Topiramate—epilepsy syndrome	5.95e-05	0.000264	CcSEcCtD
Labetalol—Syncope—Topiramate—epilepsy syndrome	5.94e-05	0.000264	CcSEcCtD
Labetalol—Palpitations—Topiramate—epilepsy syndrome	5.85e-05	0.00026	CcSEcCtD
Labetalol—Loss of consciousness—Topiramate—epilepsy syndrome	5.82e-05	0.000259	CcSEcCtD
Labetalol—Nausea—Lamotrigine—epilepsy syndrome	5.79e-05	0.000257	CcSEcCtD
Labetalol—Feeling abnormal—Pregabalin—epilepsy syndrome	5.77e-05	0.000256	CcSEcCtD
Labetalol—Paraesthesia—Gabapentin—epilepsy syndrome	5.77e-05	0.000256	CcSEcCtD
Labetalol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.73e-05	0.000255	CcSEcCtD
Labetalol—Dyspnoea—Gabapentin—epilepsy syndrome	5.73e-05	0.000254	CcSEcCtD
Labetalol—Hypertension—Topiramate—epilepsy syndrome	5.72e-05	0.000254	CcSEcCtD
Labetalol—Somnolence—Gabapentin—epilepsy syndrome	5.71e-05	0.000254	CcSEcCtD
Labetalol—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.71e-05	0.000254	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—epilepsy syndrome	5.7e-05	0.0132	CrCbGaD
Labetalol—Dyspepsia—Gabapentin—epilepsy syndrome	5.66e-05	0.000251	CcSEcCtD
Labetalol—Discomfort—Topiramate—epilepsy syndrome	5.57e-05	0.000247	CcSEcCtD
Labetalol—Urticaria—Pregabalin—epilepsy syndrome	5.57e-05	0.000247	CcSEcCtD
Labetalol—Asthenia—Valproic Acid—epilepsy syndrome	5.56e-05	0.000247	CcSEcCtD
Labetalol—Propafenone—ABCB1—epilepsy syndrome	5.55e-05	0.0128	CrCbGaD
Labetalol—Fatigue—Gabapentin—epilepsy syndrome	5.54e-05	0.000246	CcSEcCtD
Labetalol—Body temperature increased—Pregabalin—epilepsy syndrome	5.54e-05	0.000246	CcSEcCtD
Labetalol—Abdominal pain—Pregabalin—epilepsy syndrome	5.54e-05	0.000246	CcSEcCtD
Labetalol—Constipation—Gabapentin—epilepsy syndrome	5.49e-05	0.000244	CcSEcCtD
Labetalol—Pain—Gabapentin—epilepsy syndrome	5.49e-05	0.000244	CcSEcCtD
Labetalol—Pruritus—Valproic Acid—epilepsy syndrome	5.48e-05	0.000244	CcSEcCtD
Labetalol—Confusional state—Topiramate—epilepsy syndrome	5.45e-05	0.000242	CcSEcCtD
Labetalol—Oedema—Topiramate—epilepsy syndrome	5.41e-05	0.00024	CcSEcCtD
Labetalol—Shock—Topiramate—epilepsy syndrome	5.32e-05	0.000236	CcSEcCtD
Labetalol—Diarrhoea—Valproic Acid—epilepsy syndrome	5.3e-05	0.000236	CcSEcCtD
Labetalol—Feeling abnormal—Gabapentin—epilepsy syndrome	5.3e-05	0.000235	CcSEcCtD
Labetalol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.25e-05	0.000233	CcSEcCtD
Labetalol—Hyperhidrosis—Topiramate—epilepsy syndrome	5.23e-05	0.000232	CcSEcCtD
Labetalol—Hypersensitivity—Pregabalin—epilepsy syndrome	5.16e-05	0.000229	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—epilepsy syndrome	5.16e-05	0.0119	CrCbGaD
Labetalol—Dizziness—Valproic Acid—epilepsy syndrome	5.13e-05	0.000228	CcSEcCtD
Labetalol—Urticaria—Gabapentin—epilepsy syndrome	5.1e-05	0.000227	CcSEcCtD
Labetalol—Abdominal pain—Gabapentin—epilepsy syndrome	5.08e-05	0.000226	CcSEcCtD
Labetalol—Body temperature increased—Gabapentin—epilepsy syndrome	5.08e-05	0.000226	CcSEcCtD
Labetalol—Flurbiprofen—ALB—epilepsy syndrome	5.08e-05	0.0117	CrCbGaD
Labetalol—Hypotension—Topiramate—epilepsy syndrome	5.05e-05	0.000224	CcSEcCtD
Labetalol—Asthenia—Pregabalin—epilepsy syndrome	5.03e-05	0.000223	CcSEcCtD
Labetalol—Pruritus—Pregabalin—epilepsy syndrome	4.96e-05	0.00022	CcSEcCtD
Labetalol—Vomiting—Valproic Acid—epilepsy syndrome	4.93e-05	0.000219	CcSEcCtD
Labetalol—Rash—Valproic Acid—epilepsy syndrome	4.89e-05	0.000217	CcSEcCtD
Labetalol—Dermatitis—Valproic Acid—epilepsy syndrome	4.88e-05	0.000217	CcSEcCtD
Labetalol—Headache—Valproic Acid—epilepsy syndrome	4.86e-05	0.000216	CcSEcCtD
Labetalol—Paraesthesia—Topiramate—epilepsy syndrome	4.85e-05	0.000216	CcSEcCtD
Labetalol—Dyspnoea—Topiramate—epilepsy syndrome	4.82e-05	0.000214	CcSEcCtD
Labetalol—Somnolence—Topiramate—epilepsy syndrome	4.81e-05	0.000213	CcSEcCtD
Labetalol—Diarrhoea—Pregabalin—epilepsy syndrome	4.79e-05	0.000213	CcSEcCtD
Labetalol—Dyspepsia—Topiramate—epilepsy syndrome	4.76e-05	0.000211	CcSEcCtD
Labetalol—Hypersensitivity—Gabapentin—epilepsy syndrome	4.73e-05	0.00021	CcSEcCtD
Labetalol—Fatigue—Topiramate—epilepsy syndrome	4.66e-05	0.000207	CcSEcCtD
Labetalol—Dizziness—Pregabalin—epilepsy syndrome	4.63e-05	0.000206	CcSEcCtD
Labetalol—Constipation—Topiramate—epilepsy syndrome	4.62e-05	0.000205	CcSEcCtD
Labetalol—Pain—Topiramate—epilepsy syndrome	4.62e-05	0.000205	CcSEcCtD
Labetalol—Asthenia—Gabapentin—epilepsy syndrome	4.61e-05	0.000205	CcSEcCtD
Labetalol—Nausea—Valproic Acid—epilepsy syndrome	4.6e-05	0.000204	CcSEcCtD
Labetalol—Ketoprofen—ALB—epilepsy syndrome	4.6e-05	0.0106	CrCbGaD
Labetalol—Pruritus—Gabapentin—epilepsy syndrome	4.55e-05	0.000202	CcSEcCtD
Labetalol—Vomiting—Pregabalin—epilepsy syndrome	4.46e-05	0.000198	CcSEcCtD
Labetalol—Feeling abnormal—Topiramate—epilepsy syndrome	4.45e-05	0.000198	CcSEcCtD
Labetalol—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.42e-05	0.000196	CcSEcCtD
Labetalol—Rash—Pregabalin—epilepsy syndrome	4.42e-05	0.000196	CcSEcCtD
Labetalol—Dermatitis—Pregabalin—epilepsy syndrome	4.41e-05	0.000196	CcSEcCtD
Labetalol—Diarrhoea—Gabapentin—epilepsy syndrome	4.4e-05	0.000195	CcSEcCtD
Labetalol—Headache—Pregabalin—epilepsy syndrome	4.39e-05	0.000195	CcSEcCtD
Labetalol—Urticaria—Topiramate—epilepsy syndrome	4.29e-05	0.000191	CcSEcCtD
Labetalol—Abdominal pain—Topiramate—epilepsy syndrome	4.27e-05	0.00019	CcSEcCtD
Labetalol—Body temperature increased—Topiramate—epilepsy syndrome	4.27e-05	0.00019	CcSEcCtD
Labetalol—Dizziness—Gabapentin—epilepsy syndrome	4.25e-05	0.000189	CcSEcCtD
Labetalol—Nausea—Pregabalin—epilepsy syndrome	4.16e-05	0.000185	CcSEcCtD
Labetalol—Vomiting—Gabapentin—epilepsy syndrome	4.09e-05	0.000181	CcSEcCtD
Labetalol—Rash—Gabapentin—epilepsy syndrome	4.05e-05	0.00018	CcSEcCtD
Labetalol—Dermatitis—Gabapentin—epilepsy syndrome	4.05e-05	0.00018	CcSEcCtD
Labetalol—Headache—Gabapentin—epilepsy syndrome	4.03e-05	0.000179	CcSEcCtD
Labetalol—Hypersensitivity—Topiramate—epilepsy syndrome	3.98e-05	0.000177	CcSEcCtD
Labetalol—Asthenia—Topiramate—epilepsy syndrome	3.88e-05	0.000172	CcSEcCtD
Labetalol—Pruritus—Topiramate—epilepsy syndrome	3.82e-05	0.00017	CcSEcCtD
Labetalol—Nausea—Gabapentin—epilepsy syndrome	3.82e-05	0.00017	CcSEcCtD
Labetalol—Diarrhoea—Topiramate—epilepsy syndrome	3.7e-05	0.000164	CcSEcCtD
Labetalol—Dizziness—Topiramate—epilepsy syndrome	3.57e-05	0.000159	CcSEcCtD
Labetalol—Vomiting—Topiramate—epilepsy syndrome	3.44e-05	0.000153	CcSEcCtD
Labetalol—Rash—Topiramate—epilepsy syndrome	3.41e-05	0.000151	CcSEcCtD
Labetalol—Dermatitis—Topiramate—epilepsy syndrome	3.41e-05	0.000151	CcSEcCtD
Labetalol—Headache—Topiramate—epilepsy syndrome	3.39e-05	0.00015	CcSEcCtD
Labetalol—Nausea—Topiramate—epilepsy syndrome	3.21e-05	0.000143	CcSEcCtD
Labetalol—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	1.84e-05	0.000224	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	1.84e-05	0.000224	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR7—epilepsy syndrome	1.84e-05	0.000224	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	1.8e-05	0.00022	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.79e-05	0.000218	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HBEGF—epilepsy syndrome	1.78e-05	0.000217	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.77e-05	0.000215	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	1.76e-05	0.000215	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	1.76e-05	0.000215	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	1.76e-05	0.000214	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.75e-05	0.000214	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT3—epilepsy syndrome	1.75e-05	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	1.75e-05	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	1.75e-05	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	1.75e-05	0.000213	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—POMC—epilepsy syndrome	1.74e-05	0.000212	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.73e-05	0.000211	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	1.73e-05	0.000211	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	1.73e-05	0.000211	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	1.72e-05	0.00021	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADAM10—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.71e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL2—epilepsy syndrome	1.7e-05	0.000207	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.67e-05	0.000204	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	1.67e-05	0.000204	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.64e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.64e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	1.64e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.64e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.64e-05	0.0002	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—S100B—epilepsy syndrome	1.62e-05	0.000197	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	1.61e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.61e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.61e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	1.6e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SOCS3—epilepsy syndrome	1.6e-05	0.000195	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	1.6e-05	0.000195	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CDC42—epilepsy syndrome	1.6e-05	0.000195	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.59e-05	0.000194	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.59e-05	0.000194	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	1.57e-05	0.000191	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	1.56e-05	0.00019	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	1.55e-05	0.000189	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AVP—epilepsy syndrome	1.54e-05	0.000188	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	1.53e-05	0.000187	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	1.52e-05	0.000185	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	1.51e-05	0.000184	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	1.5e-05	0.000183	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.49e-05	0.000182	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	1.47e-05	0.00018	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HES1—epilepsy syndrome	1.46e-05	0.000178	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.45e-05	0.000177	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.45e-05	0.000177	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.42e-05	0.000174	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.42e-05	0.000173	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.42e-05	0.000173	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FYN—epilepsy syndrome	1.42e-05	0.000173	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—H2AFX—epilepsy syndrome	1.42e-05	0.000173	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.41e-05	0.000172	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.41e-05	0.000172	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MEF2C—epilepsy syndrome	1.41e-05	0.000172	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.39e-05	0.00017	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.39e-05	0.00017	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.39e-05	0.000169	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.39e-05	0.000169	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.37e-05	0.000167	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.36e-05	0.000165	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.36e-05	0.000165	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NGF—epilepsy syndrome	1.35e-05	0.000165	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.35e-05	0.000165	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.35e-05	0.000165	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.35e-05	0.000165	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.34e-05	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.34e-05	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.34e-05	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.34e-05	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.34e-05	0.000163	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.32e-05	0.000161	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.32e-05	0.000161	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.32e-05	0.000161	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR5—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.31e-05	0.00016	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.29e-05	0.000158	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.29e-05	0.000158	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.29e-05	0.000157	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR2A—epilepsy syndrome	1.29e-05	0.000157	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.27e-05	0.000155	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.26e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.25e-05	0.000152	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.25e-05	0.000152	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.24e-05	0.000152	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.24e-05	0.000152	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.23e-05	0.000149	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TSC2—epilepsy syndrome	1.22e-05	0.000149	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.22e-05	0.000149	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGT—epilepsy syndrome	1.22e-05	0.000149	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.22e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.22e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.21e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.21e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.21e-05	0.000148	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.2e-05	0.000146	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.2e-05	0.000146	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—epilepsy syndrome	1.19e-05	0.000146	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.18e-05	0.000144	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.18e-05	0.000144	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.18e-05	0.000144	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.18e-05	0.000144	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.18e-05	0.000144	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.17e-05	0.000143	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	1.17e-05	0.000143	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.16e-05	0.000142	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.16e-05	0.000141	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.15e-05	0.000141	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.14e-05	0.000139	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.14e-05	0.000139	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.14e-05	0.000139	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.13e-05	0.000138	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.13e-05	0.000138	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.13e-05	0.000138	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	1.13e-05	0.000137	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	1.12e-05	0.000137	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.12e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.12e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.11e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.11e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.11e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.11e-05	0.000136	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.11e-05	0.000135	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.1e-05	0.000135	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.09e-05	0.000133	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.09e-05	0.000133	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.09e-05	0.000133	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.09e-05	0.000133	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.07e-05	0.00013	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.06e-05	0.000129	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.04e-05	0.000127	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.03e-05	0.000126	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.03e-05	0.000126	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	1.03e-05	0.000125	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.02e-05	0.000125	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.02e-05	0.000125	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.02e-05	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.01e-05	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.01e-05	0.000123	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-05	0.000123	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	1e-05	0.000122	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	9.92e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	9.87e-06	0.00012	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	9.59e-06	0.000117	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	9.49e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	9.47e-06	0.000115	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	9.38e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	9.29e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	9.26e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	9.17e-06	0.000112	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	9.08e-06	0.000111	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	8.97e-06	0.000109	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	8.67e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	8.48e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	8.43e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	8.43e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	8.4e-06	0.000102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	8.38e-06	0.000102	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	8.33e-06	0.000102	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	8.26e-06	0.000101	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	8.25e-06	0.000101	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	8.22e-06	0.0001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	8.2e-06	0.0001	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	8.12e-06	9.91e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.1e-06	9.88e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	8.07e-06	9.85e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	8.01e-06	9.77e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	7.93e-06	9.67e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	7.84e-06	9.56e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	7.79e-06	9.51e-05	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	7.67e-06	9.36e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	7.63e-06	9.3e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	7.63e-06	9.3e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	7.6e-06	9.27e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	7.46e-06	9.1e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	7.38e-06	9e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	7.25e-06	8.84e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	7.24e-06	8.83e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	7.18e-06	8.76e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	7.09e-06	8.65e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	7.09e-06	8.65e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	7.08e-06	8.64e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	6.97e-06	8.5e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	6.95e-06	8.47e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	6.94e-06	8.46e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	6.94e-06	8.46e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	6.91e-06	8.42e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	6.8e-06	8.29e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	6.69e-06	8.16e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	6.66e-06	8.12e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	6.62e-06	8.08e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	6.59e-06	8.04e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	6.54e-06	7.98e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	6.52e-06	7.95e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	6.52e-06	7.95e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TH—epilepsy syndrome	6.49e-06	7.92e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	6.45e-06	7.87e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	6.09e-06	7.43e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	5.96e-06	7.27e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	5.96e-06	7.27e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	5.83e-06	7.11e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.42e-06	6.61e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	5.39e-06	6.57e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.35e-06	6.52e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	5.27e-06	6.43e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.2e-06	6.34e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	5e-06	6.1e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	4.9e-06	5.98e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	4.89e-06	5.97e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	4.84e-06	5.9e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	4.8e-06	5.85e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.55e-06	5.55e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	4.51e-06	5.5e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.45e-06	5.43e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	4.41e-06	5.38e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	4.38e-06	5.34e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	4.29e-06	5.23e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	4.26e-06	5.2e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.24e-06	5.17e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	4.17e-06	5.09e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.15e-06	5.07e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	4.13e-06	5.04e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	4.11e-06	5.02e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	4.04e-06	4.93e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	3.93e-06	4.79e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	3.84e-06	4.69e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	3.83e-06	4.67e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-06	4.57e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.57e-06	4.35e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.25e-06	3.97e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.85e-06	3.47e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	2.44e-06	2.98e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-06	2.91e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.43e-06	1.75e-05	CbGpPWpGaD
